Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
VALID Act (HR 4128/S 2209); General Issues related to data privacy and security
Veteran Federal Procurement Entrepreneurship Training Program Act
Client: TEMPUS LABS INC · Firm: TEMPUS LABS INC
VALID Act (HR 4128/S 2209); General Issues related to data privacy and security
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEMPUS LABS INC via TEMPUS LABS INC
2023 · fourth_quarter · 4T
Data Privacy; Artificial Intelligence/Machine Learning in healthcare. Reimbursement for AI in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversifying clinical trials through data and technology.
General issues related to Artificial Intelligence in healthcare. General Issues related to healthcare data privacy and security.
Source: Senate LDA
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs within Omnibus Bill (H.R. 2617 ); Issues related to data privacy and security House legislation (H.R. 8152).
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209) and Omnibus legislation (H.R. 2617). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act (HR 4128/S.2209); General Issues related to data privacy and security.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs within Omnibus Bill (H.R. 2617 ); Issues related to data privacy and security House legislation (H.R. 8152).
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cures 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209) and Omnibus legislation (H.R. 2617). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing;The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation. Cures 2.0 (H.R. 6000).
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cure 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667); Issues related to data privacy and security House legislation (H.R. 8152).
Precision Medicine Answers for Kids Today Act
Client: TEMPUS LABS INC · Firm: TEMPUS LABS INC
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cure 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Precision Medicine Answers for Kids Today Act
Client: TEMPUS LABS INC · Firm: TEMPUS LABS INC
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cures 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cure 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cures 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act of 2021 (HR 4128/S.2209); Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation. Cures 2.0 (H.R. 6000).
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: TEMPUS LABS INC · Firm: TEMPUS LABS INC
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: TEMPUS LABS INC · Firm: TEMPUS LABS INC
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Increasing overall access to and diversity of clinical trials.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667); Issues related to data privacy and security House legislation (H.R. 8152).
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs within Omnibus Bill (H.R. 2617 ); Issues related to data privacy and security House legislation (H.R. 8152).
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Issues related to cancer diagnostic testing; Medicare coverage of cancer screening and molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cure 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209) and Omnibus legislation (H.R. 2617). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act of 2021 (HR 4128/S.2209); Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation. Cures 2.0 (H.R. 6000).
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing;The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act (HR 4128/S.2209); General Issues related to data privacy and security.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs within Omnibus Bill (H.R. 2617 ); Issues related to data privacy and security House legislation (H.R. 8152).
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cures 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667); Issues related to data privacy and security House legislation (H.R. 8152).
VALID Act of 2021 (HR 4128/S.2209); cancer prevention; diversity in clinical trials; Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation.
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Delays in Protecting Access to Medicare Act (PAMA) cuts to labs through the Protecting American Farmers from Sequester Cuts Act.
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Delays in Protecting Access to Medicare Act (PAMA) cuts to labs through the Protecting American Farmers from Sequester Cuts Act.
VALID Act of 2021 (HR 4128/S.2209); cancer prevention; diversity in clinical trials; Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation.
CY 2024 Clinical Lab Fee Schedule Preliminary Determinations on Genomic Sequencing Procedure Codes; Transitional Coverage for Emerging Technologies; Precision medicine; General legislation on AI in healthcare
Access and reimbursement to advanced genomic testing for cancer; Artificial Intelligence in healthcare; Increasing overall access to and diversity of clinical trials. Advancing Real World Data and Real World Evidence in research and development.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS INC via TEMPUS LABS INC
2023 · third_quarter · Q3
Cancer diagnostic testing reimbursement; Transitional Coverage for Emerging Technologies (TCET Notice); Medicare coverage of molecular and advanced genomic testing tests; Precision medicine
General issues related to Artificial Intelligence in healthcare. General Issues related to healthcare data privacy and security.
Access and reimbursement to advanced genomic testing for cancer; Artificial Intelligence in healthcare diagnostics; Increasing overall access to and diversity of clinical trials. Advancing Real World Data and Real World Evidence in research and development.
Data Privacy; Artificial Intelligence/Machine Learning in healthcare. Reimbursement for AI in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversifying clinical trials through data and technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS INC via TEMPUS LABS INC
2023 · second_quarter · Q2
Cancer diagnostic testing coverage and reimbursement; Transitional Coverage for Emerging Technologies (TCET Notice); Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security.
Access and reimbursement to advanced genomic testing for cancer; Artificial Intelligence in healthcare; Providing an appropriate regulatory model for advanced genomic cancer testing. Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence in research and development.
General Issues related to healthcare data privacy and security. General issues related to Artificial Intelligence in healthcare.
Data Privacy; Artificial Intelligence/Machine Learning in healthcare. Reimbursement for AI in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS INC via TEMPUS LABS INC
2023 · first_quarter · Q1
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing. Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence in research and development.
VALID Act (HR 4128/S 2209); General Issues related to data privacy and security
Issues related to cancer diagnostic testing approval and reimbursement; Medicare coverage of molecular and advanced genomic testing tests;Precision medicine; Health care issues related to data privacy and security.
Data Privacy; Artificial Intelligence/Machine Learning in healthcare. Reimbursement for AI in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS INC via TEMPUS LABS INC
2022 · fourth_quarter · 4A
VALID Act (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R.7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing;The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPUS LABS INC via TEMPUS LABS INC
2022 · fourth_quarter · 4A
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing. Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence in research and development.
VALID Act (HR 4128/S.2209); General Issues related to data privacy and security.
Data Privacy; Artificial Intelligence/Machine Learning in healthcare. Reimbursement for AI in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
TEMPUS LABS INC via TEMPUS LABS INC
2022 · fourth_quarter · Q4
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs within Omnibus Bill (H.R. 2617 ); Issues related to data privacy and security House legislation (H.R. 8152).
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209) and Omnibus legislation (H.R. 2617). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
TEMPUS LABS INC via TEMPUS LABS INC
2022 · third_quarter · Q3
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Diversity of clinical trials.
Access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; The VALID Act (HR 4128 and S 2209). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667), (H.R. 6833); Issues related to data privacy and security House legislation (H.R. 8152).
TEMPUS LABS INC via TEMPUS LABS INC
2022 · second_quarter · Q2
Data Privacy(H.R. 8152).; Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Increasing overall access to and diversity of clinical trials.
VALID Act of 2021 (HR 4128/S.2209); Issues related to proposals on reauthorization of the FDA drug and device user fee programs (S.4348/H.R. 7667); Issues related to data privacy and security House legislation (H.R. 8152).
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cures 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
TEMPUS LABS INC via TEMPUS LABS INC
2022 · first_quarter · Q1
Issues related to cancer diagnostic testing; Medicare coverage of cancer screening and molecular and advanced genomic testing tests; Precision medicine; General privacy and data security and uses issues in draft proposed legislation.
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Cure 2.0 (H.R. 6000). Precision Medicine Answers for Kids Today Act (H.R.5989). Increasing overall access to and diversity of clinical trials. Advancing acceptance of Real World Data and Real World Evidence.
TEMPUS LABS INC via TEMPUS LABS INC
2021 · fourth_quarter · Q4
Data Privacy (draft legislation); Artificial Intelligence/Machine Learning in healthcare
Ensuring access and reimbursement to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing, The VALID Act (HR 4128 and S 2209). Delays in Protecting Access to Medicare Act (PAMA) cuts to labs through the Protecting American Farmers from Sequester Cuts Act.
Issues related to cancer diagnostic testing; Medicare coverage of cancer screening and molecular and advanced genomic testing tests on the Local Coverage Determination level; Precision medicine; General privacy and data security and uses issues in draft proposed legislation.
TEMPUS LABS INC via TEMPUS LABS INC
2021 · fourth_quarter · RR
Healthcare (including Medicare and Medicaid) coverage and access, reimbursement Diagnostic tests oversight and regulations FDA, MDUFA Advanced diagnostics, digital health, Artificial Intelligence, Machine Learning
Healthcare (including Medicare and Medicaid) coverage and access, reimbursement Diagnostic tests oversight and regulations FDA, MDUFA Advanced diagnostics, digital health, Artificial Intelligence, Machine Learning
Healthcare (including Medicare and Medicaid) coverage and access, reimbursement Diagnostic tests oversight and regulations FDA, MDUFA Advanced diagnostics, digital health, Artificial Intelligence, Machine Learning
Issues related to cancer diagnostic testing approval and reimbursement; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to cancer diagnostic testing; Medicare coverage of molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Issues related to cancer diagnostic testing; Medicare coverage of cancer screening and molecular and advanced genomic testing tests; Precision medicine; Health care issues related to data privacy and security House legislation (H.R. 8152).
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
VALID Act of 2021 (HR 4128/S.2209); Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation. Cures 2.0 (H.R. 6000).
Data Privacy (draft legislation); Artificial Intelligence/Machine Learning in healthcare. Increasing multi-modal data in medical research and innovation. Advancing acceptance of Real World Data and Real World Evidence. Increasing overall access to and diversity of clinical trials.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
VALID Act of 2021 (HR 4128/S.2209); cancer prevention; diversity in clinical trials; Government response to COVID-19; Issues related to the draft proposals on reauthorization of the FDA drug and device user fee programs (legislation not introduced); Issues related to data privacy and security draft House legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Healthcare (including Medicare and Medicaid) coverage and access, reimbursement Diagnostic tests oversight and regulations FDA, MDUFA Advanced diagnostics, digital health, Artificial Intelligence, Machine Learning
Healthcare (including Medicare and Medicaid) coverage and access, reimbursement Diagnostic tests oversight and regulations FDA, MDUFA Advanced diagnostics, digital health, Artificial Intelligence, Machine Learning